UPDATE: JP Morgan Upgrades Teva Pharmaceuticals - Teva Pharmaceutical Indus (NYSE:TEVA)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

On Friday, JP Morgan upgraded shares of

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Teva Pharmaceuticals

(NYSE: TEVA) from Underweight to Neutral and raised the profit target to $49.Analyst Chris Schott is encouraged by “favorable initial Copaxone 3x weekly trends and the potential for additional cost cutting activity,” but remains “less enthusiastic around Teva's organic growth prospects and its P&L reliance on Copaxone.”Schott expects Teva management's “willingness to consider larger business development opportunities will be well received.”Shares of Teva are up 21 percent year-to-date and up 1.8 percent to $48.82 during Friday's session.